Verition Fund Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $978K | Buy |
+12,500
| New | +$852K | 0.01% | 1423 |
|
|
2026
Q1 | – | Sell |
-27,995
| Closed | -$1.88M | – | 2824 |
|
|
2025
Q4 | $1.88M | Sell |
27,995
-40,172
| -59% | -$2.7M | 0.01% | 1661 |
|
|
2025
Q3 | $5M | Buy |
68,167
+34,635
| +103% | +$2.3M | 0.02% | 1162 |
|
|
2025
Q2 | $1.74M | Buy |
33,532
+9,826
| +41% | +$559K | 0.01% | 2050 |
|
|
2025
Q1 | $1.51M | Sell |
23,706
-15,519
| -40% | -$902K | 0.01% | 1783 |
|
|
2024
Q4 | $1.88M | Buy |
39,225
+35,545
| +966% | +$1.82M | 0.01% | 1592 |
|
|
2024
Q3 | $211K | Sell |
3,680
-956
| -21% | -$54.8K | ﹤0.01% | 2855 |
|
|
2024
Q2 | $243K | Sell |
4,636
-1,607
| -26% | -$70.5K | ﹤0.01% | 2479 |
|
|
2024
Q1 | $254K | Sell |
6,243
-3,588
| -36% | -$135K | ﹤0.01% | 2383 |
|
|
2023
Q4 | $363K | Sell |
9,831
-496
| -5% | -$18.7K | ﹤0.01% | 1685 |
|
|
2023
Q3 | $394K | Buy |
10,327
+940
| +10% | +$38.5K | ﹤0.01% | 1578 |
|
|
2023
Q2 | $339K | Sell |
9,387
-2,156
| -19% | -$73.6K | ﹤0.01% | 1473 |
|
|
2023
Q1 | $441K | Buy |
+11,543
| New | +$541K | 0.01% | 1310 |
|
|
2022
Q3 | – | Sell |
-14,877
| Closed | -$655K | – | 3117 |
|
|
2022
Q2 | $655K | Buy |
+14,877
| New | +$643K | 0.01% | 1274 |
|
|
2022
Q1 | – | Sell |
-106,663
| Closed | -$4.29M | – | 2844 |
|
|
2021
Q4 | $4.29M | Buy |
+106,663
| New | +$3.98M | 0.03% | 434 |
|
|
2021
Q3 | – | Sell |
-36,260
| Closed | -$1.65M | – | 2074 |
|
|
2021
Q2 | $1.65M | Buy |
36,260
+27,374
| +308% | +$1.21M | 0.02% | 605 |
|
|
2021
Q1 | $370K | Buy |
+8,886
| New | +$406K | ﹤0.01% | 1009 |
|
|
2020
Q4 | – | Sell |
-14,932
| Closed | -$392K | – | 1212 |
|
|
2020
Q3 | $392K | Buy |
+14,932
| New | +$416K | 0.01% | 678 |
|
|
2020
Q2 | – | Sell |
-16,890
| Closed | -$304K | – | 1099 |
|
|
2020
Q1 | $304K | Sell |
16,890
-57,796
| -77% | -$1.1M | 0.01% | 426 |
|
|
2019
Q4 | $1.32M | Buy |
74,686
+11,875
| +19% | +$206K | 0.02% | 369 |
|
|
2019
Q3 | $974K | Buy |
62,811
+24,241
| +63% | +$399K | 0.03% | 425 |
|
|
2019
Q2 | $663K | Buy |
+38,570
| New | +$622K | 0.02% | 574 |
|
|
2018
Q4 | – | Sell |
-10,044
| Closed | -$182K | – | 995 |
|
|
2018
Q3 | $182K | Buy |
+10,044
| New | +$176K | 0.01% | 1183 |
|
|
2017
Q3 | – | Sell |
-20,499
| Closed | -$263K | – | 1256 |
|
|
2017
Q2 | $263K | Buy |
20,499
+6,866
| +50% | +$91.7K | 0.03% | 730 |
|
|
2017
Q1 | $177K | Buy |
+13,633
| New | +$172K | 0.02% | 1062 |
|
|
2014
Q3 | – | Sell |
-16,199
| Closed | -$160K | – | 788 |
|
|
2014
Q2 | $160K | Buy |
+16,199
| New | +$137K | 0.02% | 571 |
|
Other funds holding HALO
Verition Fund Management's HALO Position: Q2 2026 in Review
Verition Fund Management opened a new position in Halozyme (HALO) in Q2 2026: 12,500 shares worth $978K. The stake represents 0.01% of the portfolio and ranks #1423 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in HALO as recently as Q4 2025.
Verition Fund Management first reported a position in HALO in Q2 2014 and has held it in 26 quarters since. The position peaked at $5M in Q3 2025. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Verition Fund Management held 12,500 shares of Halozyme worth $978K as of Q2 2026.
- Halozyme was a new Verition Fund Management position in Q2 2026.
- Halozyme made up 0.01% of Verition Fund Management's portfolio in Q2 2026, its #1423 holding.
- Verition Fund Management first reported a position in Halozyme in Q2 2014 and has held it in 26 quarters since.
- Verition Fund Management's Halozyme position peaked at $5M in Q3 2025.
- 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.